BC Extra | May 7, 2019
Financial News

Liver cell therapy company Promethera grows Asian investor base with D round

Belgian company Promethera added new Japanese and Korean investors in its series D round Monday, as part of its focus on growing its Asia network to leverage the "openness" to stem cell therapies in the...
BioCentury | Jun 22, 2018
Finance

Regenerating eastward

Having capitalized on the cell therapy expertise and manufacturing incentives of its European home base, Promethera Biosciences S.A. is expanding to Japan to tap the commitment to regenerative medicines among investors, pharmas and regulators. After...
BC Week In Review | Apr 13, 2018
Company News

Promethera acquires antibody play Baliopharm

Liver disease company Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) said it acquired antibody developer Baliopharm AG (Basel, Switzerland). Promethera declined to disclose financial details. Promethera also raised €9.3 million ($11.4 million) on April 10 through the...
BC Extra | Apr 10, 2018
Company News

Promethera acquires antibody play Baliopharm

Liver disease company Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) said it acquired antibody developer Baliopharm AG (Basel, Switzerland). Promethera declined to disclose financial details. Promethera also raised €9.3 million ($11.4 million) through the sale of convertible...
Items per page:
1 - 4 of 4